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Background and aims: Increasing the prevalence of nosocomial infections by multidrug resistant (MDR) Pseudomonas aeruginosa has 
severely challenged the choice of treatment and led to an increased mortality rate. Thus, this study investigated the frequency of class I and 
II integrons and its association with MDR.
Materials and Methods: A total of 175 P. aeruginosa isolates were collected from Shahrekord teaching hospitals and Isfahan Shahid 
Chamran hospital during 12 months (from April 2008 to March 2009). Antibiotic susceptibility was determined by disc diffusion according 
to the Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing. The E-test strips of imipenem, ciprofloxacin, 
and amikacin were used to identify the minimum inhibitory concentration and MDR bacteria. Finally, the frequency of class I and II 
integrons genes was evaluated by using the polymerase chain reaction test.
Results: The highest antibiotic resistance and the highest susceptibility belonged to meropenem (86.9%) and polymyxin B (96.0%) by disc 
diffusion, respectively. By the E-test, the highest and lowest resistance rates were reported for imipenem (97.2%) and ciprofloxacin (86.8%), 
respectively. The frequency of MDR strains was 82.3% as well. The frequency of class I and II integrons was 57.7% and 17.7% in all P. 
aeruginosa isolates, as well as 68.1%and 21.5% in the MDR isolates, respectively. There was also a significant correlation between I and 
II integrons and MDR.
Conclusion: Overall, the resistance to different antibiotics and the frequency of MDR strains among the studied P. aeruginosa isolates 
were very high. There was also a significant correlation between integrons and multidrug resistance. Regarding the role of integrons in 
the transfer of drug-resistant genes and the development of MDR strains, the use of appropriate diet and accurate determination of the 
susceptibility pattern of P. aeruginosa isolates are considered necessary.
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Introduction 
Pseudomonas aeruginosa is an oxidase-positive gram-
negative, mobile, spore-free, and aerobic bacterium. This 
bacterium is not able to ferment carbohydrates and grows 
at 37-42°C (1-3). In addition, P. aeruginosa accounts for 
11%-13.8% of hospital-acquired infections, but in the 
intensive care unit, this rate reaches 13.8-22.6% (4). 
This organism is the third leading bacterial cause of 
the development of nosocomial infections, followed by 
Staphylococcus aureus and Escherichia coli (5). The rapid 
spread of multidrug resistant (MDR) bacteria is a serious 
public health problem (6). Therefore, the World Health 
Organization (WHO) has named the year 2011 as the year 
of antibiotic resistance (7).
The increased prevalence of nosocomial infections with 
MDR P. aeruginosa strains has seriously challenged the 
treatment choice and thus has led to an increased mortality 
rate (8). P. aeruginosa is an important clinical pathogen 
that has an inherent resistance to various antimicrobial 
agents. Genes that increase antibiotic resistance of P. 
aeruginosa (e.g., beta-lactams, aminoglycosides, and 
fluoroquinolones) may be produced by this bacterium as 
well. The acquisition of genes in horizontal gene transfer 
is dependent on mobile genetic elements (MGEs) such as 
integron, transposon, and plasmid.
These MGEs play an important role in the spread of 
resistance genes among the bacteria. Further, the genes 
transferred by the integron cause the coding of multiple 
drug resistance mechanisms such as beta-lactams, 
aminoglycosides, and other antimicrobial agents (9-
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12). So far, four classes of integrons have been identified 
in gram-negative bacterial isolates. However, class I 
integron has the highest prevalence among the clinical 
isolates and can carry one or more gene cassettes, which 
can result in resistance to aminoglycosides, beta-lactams, 
fluoroquinolones, macronutrients, and macrolides (12). 
Given the presence of antibiotic resistance genes on the 
integron and the possibility of the rapid spread of these 
genes among different bacterial species, identifying the 
integrons provides useful information on the prevalence of 
MDR P. aeruginosa and how resistance genes are spread.
Materials and Methods
In this descriptive-analytical study, 175 P. aeruginosa 
isolates were collected from blood, urine, ulcers, burns, 
respiratory secretions, peritoneum, and cerebrospinal 
fluid specimens in the teaching hospitals affiliated with 
Shahrekord University of Medical Sciences and Isfahan 
Shahid Chamran hospital from April 2016 to March 2017.
Aftercompleting the checklist of patient characteristics, the 
specimens were transferred to the Microbiology Laboratory 
of the Shahrekord University of Medical Sciences. The 
specimens were then retested for the presence of P. aeruginosa 
strains by using certain standard laboratory tests such as 
hot dyeing, oxidase and catalase tests, citrate mobility and 
consumption test, pigment production, cultivation on a 
specific cetrimide agar medium (Merck, Germany), and 
oxidative fermentative test.
Next, antibiotic susceptibility was determined by 
disc diffusion (Kirby Bauer) according to the CLSI 
Antimicrobial Susceptibility Testing (13). For this purpose, 
the Mueller-Hinton agar (Merck, Germany) was first 
prepared and then its PH was adjusted to 2.7-7.2. Then, a 
standard microbial suspension was prepared based on the 
0.5 McFarland standard and cultured by using a cotton 
swab. Furthermore, piperacillin (100 μg), piperacillin-
tazobactam (10/100 μg), ceftazidime (30 μg), cefepime (30 
μg), aztreonam (30 μg), imipenem (10 μg), meropenem (10 
μg), doripenem (10 μg), gentamicin (10 μg), amikacin (30 
μg), tobramycin (10 μg), ciprofloxacin (5 μg), levofloxacin 
(5 μg), colistin (10 μg), and polymyxin B (300 units, Mast, 
England) were placed at a distance of at least 2 cm apart. 
Then, the diameter of the inhibition zone around each 
disc was measured and the results were recorded after 24-
hour incubation at 37°C. Escherichia coli (ATCC25922) 
was utilized as the standard strain for qualitative control. 
The E-test strips of imipenem, ciprofloxacin, and amikacin 
(Liofichem, Italy) were employed to determine the 
minimum inhibitory concentration and the MDR strains.
Genomic DNA was extracted by using boiling. To this end, 
3-5 colonies of the 24-hour culture of the bacteria were first 
dissolved in 500 ml sterile distilled water and the suspension 
was stained for 15 minutes at 95°C. After centrifuging 
the suspension at 13000 rpm for 10 minutes at 4°C, 
spectrophotometry (NanoDrop) was used to determine the 
quality of the extracted DNA. If the concentration of DNA 
was appropriate, the specimen was frozen at -20°C and then 
utilized in all stages of the study. 
Using the DNA extracted from the bacteria in the 
previous steps, the polymerase chain reaction was performed 
to determine the frequency of class I and II integrons, 
and 16S ribosomal RNA in a final volume of 25 μL was 
considered as the internal control for all specimens. The 
sequences for the genes of interest were obtained from the 
National Center for Biotechnology Information (NCBI) 
and the primers were designed using the DNASIS MAX 
3.0 (Table 1). After preparing the master mix and adding 
DNA of each specimen, the microtubes were placed in the 
Mastercycler (Eppendorf, Germany) under the specified 
temperature (Table 2). To control the contamination, 
tubes without DNA (containing master mix and distilled 
water) were applied as the negative control in all stages of 
the study. Eventually, the confirmed P. aeruginosa strains 
containing the integron were used as the positive control to 
confirm the precision of the test (13-15).
Data analysis
In this study, data analysis was performed by SPSS (version 
18) using descriptive statistics (i.e., frequency, percentage, 
along with mean and standard deviation) and inferential 
statistics (i.e., the chi-square and Fisher exact tests). 
Additionally, the correlation was used to investigate the 
relationship between the components if necessary and 
P < 0.05 was considered statistically significant. 
Results
Totally, 89 (50.9%) out of 175 P. aeruginosa specimens 
were collected from female patients. The mean age of 
Table 1. Sequences of the primers used to detect class I and II integrons





Table 2. Temperature protocol and the number of cycles in thermocycler for 
performing PCR for class I and II integrons
Reaction Step Gene Temperature (°C) Time Number of Cycle
Hot Star
Int-1 95 5 min 1
Int-2 95 5 min 1
Denaturation
Int-1 95 30 s 35
Int-2 95 60 s 35
Annealing
Int-1 55 30 s 35
Int-2 53 60 s 35
Extension
Int-1 72 30 s 35
Int-2 72 60 s 35
Note. PCR: Polymerase chain reaction.
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the patients from whom the specimens were collected 
was 43.9 ± 21.9 (range; 4-89) years. In addition, the 
highest numbers of specimens were collected from 
ICU patients with 55 (26.9%) isolates. Further, most P. 
aeruginosa isolates (26.9%, n=47) were taken from urine 
specimens, followed by wound burn specimens (26.3%) 
and respiratory secretions (22.9%). The highest antibiotic 
resistance was observed for meropenem (86.9%, n=152), 
imipenem and levofloxacin (84.6%, n=148), followed by 
ciprofloxacin (81.7%, n=143) and tobramycin (80.6%, 
n=141). Besides, the highest susceptibility was obtained for 
polymyxin B (96.0%, n=168) and then colistin (95.4%, 
n=167), the related data are displayed in Figure 1.
Based on the results, 144 (82.3%) P. aeruginosa isolates 
were confirmed as MDR by the E-test after they were also 
found to be MDR by the antibiogram method. Further, 
Fisher exact test showed that there was a significant 
relationship between class I integron and resistance against 
imipenem, meropenem, tobramycin, ciprofloxacin, 
levofloxacin, and gentamicin (P < 0.05). Furthermore, 
a significant relationship was observed between class II 
integron and resistance to imipenem (P < 0.05) and class I 
and II integrons were more prevalent in imipenem-resistant 
strains (Table 3).
Among the 175 P. aeruginosa isolates, the frequencies of 
class I and II integrons were 57.7% (n: 101) 17.7% (n: 
31), respectively, and 26 (14.9%) isolates were found to 
have both integrons. Among the 144 MDR P. aeruginosa 
isolates, the frequencies of class I and II integrons were 
68.1% (n: 98) 21.5% (n: 31), respectively, and 26 (14.9%) 
isolates were found to have both integrons. Fisher’s exact 
test showed that there was a significant relationship between 
class I and II integrons and multidrug resistance (P < 0.05). 
In addition, there was a significant relationship between 
the presence of both integrons and multidrug resistance 
(P < 0.05). Class I and II integrons were more prevalent 
among the MDR isolates (Table 4).
Note. From the left to the right: Column M: DNA ladder; 
Column 1: Positive control of class I integron; Columns 
2-5, 7, and 8: Positive specimens containing class I integron 
with a product size of 234 bp; Column 6: Without class I 
integron; Column 9: Negative control.
Discussion
The presence of MGEs such as integrons in MDR 
isolates is one of the important reasons for the occurrence 
and transfer of resistance genes. Integrons have a high 
prevalence in gram-negative bacteria and cause resistance to 
most antibiotics used in the hospitals due to the acceptance 
of various drug-resistant cassettes (16).
In this study, the frequencies of class I and II integrons 
among all 175 isolates of P. aeruginosa were 57.7% and Figure 1. Antibiotic resistance percent in Pseudomonas aeruginosa 
isolates.
Table 3. Antibiotic resistance pattern of pseudomonas aeruginosa isolates with respect to the presence and absence of class I and II integrons
Antibiotic Type of Integrin Presence of Integrin No. (%) Lack of Integrin No. (%)
Imipenem
Class 1 92 (62.2) 56 (37.8)
Class 2 30 (20.3) 118 (79.7)
Meropenem
Class 1 98 (64.5) 54 (35.5)
Class 2 29 (19.1) 123 (80.9)
Tobramycin
Class 1 96 (68.1) 45 (31.9)
Class 2 28 (19.9) 113 (80.1)
Ciprofloxacin
Class 1 93 (65) 5 (35)
Class 2 30 (21) 113 (79)
Levofloxacin
Class 1 90 (60.8) 58 (39.2)
Class 2 30 (20.3) 118 (79.7)
Polymyxin B
Class 1 2 (100) 0 (0)
Class 2 0 (0) 2 (100)
Colistin
Class 1 2 (100) 0 (0)
Class 2 0 (0) 2 (100)
Gentamicin
Class 1 92 (66.2) 47 (33.8)
Class 2 92 (62.2) 47 (33.8)
Table 4. Frequencies of integrons in multidrug resistant and non-multidrug 
resistant Pseudomonas aeruginosa isolates
Integron




Class 1 98 (68.1) 3 (9.7)
Class 2 31 (21.5) 0 (0)
Class 1 and 2 26 (18.1) 0 (0)
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17.7%, respectively, and 44.4% of the isolates contained 
integron. In addition, the frequencies of class I and II 
integrons in the 144 MDR isolates were 68.1% and 21.5%, 
respectively. In total, 89.6% of these isolates had integron. 
In the study of Fonseca et al in Brazil, the prevalence rate 
of class I integron among the MDR isolates was obtained 
41.5 %, but no class II integron was observed in these 
isolates (17). Further, Yan et al showed that 76.3% of the 
MDR isolates contained class I integron and only 0.8% of 
them had class II integron (18). Similarly, Odumosu et al 
in Nigeria reported that the percentage of class I integron 
in MDR specimens was 57%, but no class II integron was 
observed in any of the isolates (9). In another study by Kor 
et al. in Malaysia, 45.6% of the MDR isolates included 
class I integron and only 2% of them contained class II 
integron (19).Likewise, Cicek et al in Turkey found that 
4.87% of MDR strains contained class I integron, while 
none of the isolates had class II integron (11). In another 
study in China, Gu et al indicated that 40.8% and 0% 
of the isolates encompassed the class I and II integrons, 
respectively (20). In another study in China, the frequency 
of class I integron among P. aeruginosa isolates was 45.8% 
(21). Moreover, Poonsuk et al in Thailand concluded 
that the frequency of class II integron in all P. aeruginosa 
isolates was 69.3% (22). Compared to non-MDR isolates, 
most studies reported high-level frequencies of integrons 
in MDR isolates, suggesting the presence of drug-resistant 
genes and the production of MDR strains by integrons. In 
addition, the integrons in different parts of the world have 
different prevalence rates, which can be due to a different 
pattern of drug resistance across the world. Additionally, 
the percentage of class I integron was found to be extremely 
higher than that of class II integron in all studies, which 
implies the greater role of class I integron in the transfer of 
resistance genes.
Carbapenems such as imipenem and meropenem 
represent an important therapeutic regimen for resistant 
P. aeruginosa infection (23).The study of Peymani et al in 
Iran showed that the percentages of imipenem-resistant 
and susceptible isolates were 26% and 55%, respectively 
(24).Yan et al also demonstrated that the lowest resistance 
was obtained against imipenem and vancomycin (18). 
In another study, Ninama et al reported 14%resistance 
to imipenem (25). The rates of resistance to meropenem 
and imipenem in this study were 86.6% and 84.6%, 
respectively, which was not consistent with the results of 
other studies. These drugs are not considered appropriate 
for treating these infections due to the high resistance of 
P. aeruginosa infections. The resistance rate to this type of 
antibiotics in our study was higher compared to those in 
other studies because most of the specimens in this study 
were collected from the patients in the burn units and the 
ICUs, and Carbapenems were routinely administered to the 
patients in these units. The excessive use of carbapenems 
to treat P. aeruginosa infections also led to widespread 
antibiotic resistance in these drugs.
The study of Fonseca et al. in Brazil showed that the highest 
antibiotic resistance (70%) was against aminoglycoside 
(17). Dubois et al in France reported 15.9% and 55.8% 
resistance to tobramycin and gentamicin, respectively (26). 
In Thailand, the rates of resistance to these two antibiotics 
were also reported to be 96% and 95%, respectively (22).
In India, Ninama et al found 63% resistance to gentamicin 
(25). In the present study, the percentages of resistance to 
gentamicin, amikacin, and tobramycin were determined to 
be 79.4%, 61.7%, and 80.6%, respectively, representing a 
rise due to the misuse of these antibiotics in recent years. In 
addition, the resistance to aminoglycosides in developing 
countries is higher than that in developed countries due 
to comparatively higher consumption of aminoglycosides.
In this study, 15 antibiotic discs were used to detect 
MDR strains, and the isolates found as resistant to at least 
six antibiotics were considered as MDR (18). Further, 
144 out of 175 P. aeruginosa isolates were MDR with a 
prevalence rate of 82%. Shahcheraghi et al observed that 
the prevalence rate of MDR specimens among 750 P. 
aeruginosa isolates was 46.5% (27); it was reported to be 
71%, 7.84%, and 18% by Fonseca et al. (17), Yan et al 
(18), and Cicek et al (11), respectively. In most studies, 
the strains with resistance to at least three antibiotics were 
identified as MDR, while in the present study, a strain 
could be considered MDR if it was resistant to at least six 
Figure 2. Agarose Gel (1%) of single-polymerase chain reaction of 
class I integron.
Note. From the left to the right: Column M: DNA ladder; Column 
1: Positive control of class I integron; Columns 2-5, 7, and 8: 
Positive specimens containing class I integron with a product size 
of 234 bp; Column 6: Without class I integron; Column 9: Negative 
control.
Figure 3. Agarose Gel (1%) of single-polymerase chain reaction of 
class II integron.
Note. From the left to the right: Column M: DNA ladder; Column 
1: Positive control of class II integron; Columns 2-5: Specimens 
containing class II integron with a product size of 787 bp; Column 
6: Negative control.
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antibiotics. However, the prevalence rate of MDR strains 
has increased compared to the past years due to the overuse 
of antibiotics in recent years. In general, the rate of MDR 
strains is higher in developing countries compared to 
developed ones. The relatively high frequency of the MDR 
isolates in our study could be attributed to the fact that half 
of the specimens were collected from the patients in the 
burn units and the ICUs.
Conclusion
The results of this study showed that resistance to various 
antibiotics and the frequency of MDR strains in P. aeruginosa 
isolates were very high. Based on the results, a remarkable 
prevalence of the integrons was found in the P. aeruginosa 
isolates and MDR strains. Given the role of integrons in the 
production of MDR strains and the challenges regarding 
the elimination of these strains, the use of appropriate diet 
and accurate determination of the susceptibility pattern 
of P. aeruginosa isolates seem necessary. Due to the ability 
of the integrons to interchange between different strains 
of bacteria involved in the development of nosocomial 
infections, it is necessary to use appropriate therapeutic 
strategies to prevent the spread of such infections and 
antibiotic resistance among different bacteria.
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